Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
Go back to Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting| (NASDAQ: SANA) | Delayed: 3.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.15 | 52 Week High | $ | |||
| Open | $3.15 | 52 Week Low | $ | |||
| Day High | $3.15 | P/E | N/A | |||
| Day Low | $3.15 | EPS | $ | |||
| Volume | 4,075 | |||||
